Related by context. All words. (Click for frequent words.) 76 Darinaparsin 73 tositumomab 73 targeted radiotherapeutic 73 R Saizen R 72 Pivotal Phase III 72 TNF Tumor Necrosis Factor 72 MAGE A3 ASCI 72 CYT# potent vascular disrupting 72 ara C 72 pan HDAC inhibitor 72 novel histone deacetylase 72 Combination REOLYSIN R 71 liposomal formulation 71 Zorbtive TM 71 cisplatin gemcitabine 71 essential thrombocythemia ET 71 lexidronam injection 71 FOLOTYN ® 71 5 fluorouracil leucovorin 71 alkylating agent 71 receptor tyrosine kinase inhibitor 71 relapsed MM 71 orally administered inhibitor 71 Meets Primary Endpoint 70 Ophena TM 70 methylnaltrexone bromide 70 CTAP# Capsules 70 Bezielle 70 IMiDs ® 70 Peginterferon alfa 2b 70 generation purine nucleoside 70 Parathyroid Hormone 70 microsphere therapy 70 Completes Patient Enrollment 70 iobenguane 70 refractory chronic lymphocytic 70 FUSILEV enhances 70 ThermoDox R 70 Personalized Immunotherapy 70 Vicinium TM 70 cysteamine bitartrate 70 ALN HPN 70 demonstrated antitumor activity 70 acetonide FA 70 intranasal formulation 70 sorafenib tablets 70 MGd 70 Phase 2b Clinical Trial 70 ALN PCS 70 samarium Sm 70 Pharmacokinetics PK 70 dasatinib Sprycel ® 70 arsenic trioxide injection 70 MKC# MT 70 Azacitidine 70 leukemia AML 70 metastatic colorectal 70 myelodysplastic myeloproliferative diseases 70 Metastatic Melanoma 70 PROSTASCINT R 70 oral prodrug 70 Orally administered 70 PNP inhibitor 69 Cloretazine ® 69 Vidaza azacitidine 69 Immunotherapeutic 69 Gliadel Wafer 69 carmustine 69 epoetin alpha 69 Initiates Clinical Trial 69 sapropterin dihydrochloride 69 histone deacetylase HDAC inhibitor 69 Ozarelix 69 hyaluronidase enzyme 69 sorafenib Nexavar 69 5 Fluorouracil 69 Granted Orphan Drug 69 Myelodysplastic Syndrome MDS 69 ospemifene 69 Cloretazine 69 severe hypersensitivity reactions 69 treat chronic sinusitis 69 PEGylated anti 69 substantially excreted 69 Tezampanel 69 chimeric monoclonal antibody 69 Intravenous Human 69 radiotherapeutic 69 Nitazoxanide 69 Receives Orphan Drug Designation 69 Onalta 69 Pafuramidine 69 Gliadel R 69 vapreotide acetate 69 Pathway Inhibitor 69 tiuxetan 69 Friedreich Ataxia FRDA 69 IL# PE#QQR 69 metastatic malignant 69 non nucleoside inhibitor 69 pan histone deacetylase 69 efaproxiral 69 Gonal f ® 69 catheter occlusion 69 PRN FDA Approves 69 Patients Treated With 69 oral picoplatin 69 Achieves Primary Endpoint 69 tumors GIST 69 Nilotinib 69 Lenocta 69 SPRYCEL ® 69 brivanib 69 Gemzar gemcitabine 69 inhibitor PPI 69 Prolongs Survival 69 Vascular Disrupting Agent 69 PEGylated Fab fragment 69 Wafer polifeprosan 69 humanized monoclonal 69 Selective Internal 68 candidates Azedra 68 Genasense ® oblimersen 68 Romidepsin 68 Omacetaxine 68 Phase #b/#a clinical 68 5 FU leucovorin 68 Pemetrexed 68 YONDELIS 68 Single Dose 68 Azedra 68 docetaxel Taxotere ® 68 induced mucositis 68 Archexin 68 TO AVOID PREGNANCY WHILE 68 histone deacetylase inhibitor 68 intravesical instillation 68 Initiates Phase II 68 Investigational Compound 68 Hsp# Inhibitor 68 delivers fluocinolone acetonide FA 68 hyperphenylalaninemia HPA due 68 ® lenalidomide 68 investigational monoclonal antibody 68 Xanafide 68 forodesine 68 Trial Evaluating 68 AAG geldanamycin analog 68 dihydrochloride 68 fallopian tube carcinoma 68 cromolyn sodium 68 cutaneous T 68 Temsirolimus 68 thalidomide Thalomid 68 NS#/#A protease 68 GVAX ® 68 trastuzumab DM1 T DM1 68 inhalation powder 68 Saizen ® 68 investigational antiplatelet agent 68 Methylnaltrexone 68 refractory acute myeloid 68 Sevelamer 68 metastatic GIST 68 Gonal f R 68 Vidaza R 68 Ovitrelle R Serostim 68 dependent kinase inhibitor 68 lucinactant 68 aripiprazole Abilify 68 Complicated Skin 68 Solazed ™ 68 Elagolix 68 systemic anaplastic large 68 estramustine 68 interferon beta 1a infertility 68 refractory cutaneous T 68 radiolabeled TM# 68 mesylate 68 Adjuvant Treatment 68 Sudhir Agrawal D.Phil 68 GTC recombinant human 68 Dose Ranging Study 68 SinuNase TM 68 erlotinib Tarceva ® 68 candidates Azedra TM 68 metastatic pancreatic 68 Luveris R Ovidrel R 68 Initiates Enrollment 68 Telithromycin 68 hormone LHRH antagonist 68 Shows Statistically Significant 68 nucleotide analogue 68 CTAP# 68 humanised monoclonal antibody 68 REPRONEX R menotropins 68 Gonal f R follitropin 68 Tarceva TM 68 Mg Uk 68 ZACTIMA 68 Initiate Clinical Trial 68 TKB# 68 Aztreonam lysine 68 Transdermal Patch 68 mertansine 68 vinca alkaloids 68 Panzem NCD 68 radiation enteritis 68 huC# DM4 68 2 methoxyestradiol 68 pralatrexate injection folate analogue 67 IMA# 67 molecular imaging radiopharmaceutical 67 papillary renal cell carcinoma 67 AKT inhibitor 67 MOVIPREP R 67 cell lymphoma CTCL 67 gefitinib Iressa 67 Cetrorelix 67 selective modulator 67 Cutaneous T 67 Begins Dosing 67 Epratuzumab 67 sodium thiosulfate STS 67 Mg Usa 67 IMiDs R 67 NeuroSTAT ® 67 ceftazidime 67 Recombinant Human 67 TNF Blockers 67 Degarelix 67 lintuzumab SGN 67 Clolar ® 67 Hormone Refractory Prostate Cancer 67 novel VDA molecule 67 Luteinizing Hormone Releasing Hormone 67 LymphoStat B belimumab 67 Phase III Clinical Trial 67 LymphoStat B TM 67 Albuferon TM 67 Paraplatin ® 67 telomerase therapeutic 67 phase III isavuconazole 67 Aflibercept 67 Civacir 67 PDX pralatrexate 67 cilengitide 67 non splenectomized 67 including eniluracil ADH 67 vinorelbine tartrate 67 Afatinib 67 sulindac 67 topically applied SEPA 67 BARACLUDE R 67 Presents Positive 67 cetuximab Erbitux R 67 alfa 2a 67 Naive Patients 67 TLK# 67 malignant ascites 67 Investigational Treatment 67 busulfan 67 ciprofloxacin hydrochloride 67 Acetate Rectal Suppositories 67 cytomegalovirus immune globulin 67 non resectable 67 Liprotamase 67 Prodarsan R 67 MEK Inhibitor 67 virus HCV protease inhibitor 67 topoisomerase II inhibitor 67 LHRH receptor positive 67 Diffuse Large B 67 modified glutathione analog 67 Gel repository corticotropin injection 67 investigational oral hepatitis C 67 luteinizing hormone releasing 67 Panzem R NCD 67 Myocet 67 Submits NDA 67 Previously Untreated 67 oropharyngeal candidiasis OPC 67 epithelial tumors 67 Vidaza ® 67 antibody MAb 67 BrachySil TM 67 Refractory Hodgkin Lymphoma 67 HGS ETR1 mapatumumab 67 vinca alkaloid 67 potent CYP#A# inhibitors 67 acyclovir Lauriad R 67 Commences Phase 67 Xyfid TM 67 Novel Oral 67 targeted antifolate 67 lenalidomide Revlimid R 67 sunitinib Sutent 67 liposomal amphotericin B 67 OMNARIS HFA 67 Tesetaxel 67 Valopicitabine 67 receiving INTRON 67 Evoltra ® 67 Solazed TM 67 Phase IIb Trial 67 R lenalidomide 67 induced macular edema 67 riboflavin vitamin B2 67 pharmacologically active isomer 67 Serostim R 67 generation Hsp# inhibitor 67 EOquin TM 67 Pooled Analysis 67 fosbretabulin 67 advanced metastatic renal 67 OMP #M# 67 5 HT3 antagonist 67 Fast Track Status 67 Known hypersensitivity 67 Patients Receiving 67 Intravitreal 67 chemotherapy cisplatin 67 VISICOL R 67 Leucovorin 67 liposomal doxorubicin 67 Amrubicin 67 Elevated serum 67 recurrent metastatic 67 Files IND 67 Zemiva TM 67 Xcytrin R 67 Bazedoxifene 67 MCSP respectively 67 novel emulsion formulation 67 Kinase Inhibitor 66 Leukine ® 66 class anticancer quinolone 66 R abatacept 66 personalized dendritic cell 66 Serostim ® 66 Cleviprex TM clevidipine 66 BUPHENYL 66 selective kinase inhibitor 66 refractory gout 66 dasatinib Sprycel 66 Cotara ® 66 Vitrasert R 66 Lubiprostone 66 Alfacell proprietary ribonuclease 66 Atypical Hemolytic Uremic Syndrome 66 metastatic gastric 66 pioglitazone HCl 66 Initiate Phase 66 bevacizumab Avastin ® 66 NB S# strontium malonate 66 trial evaluating PRX# 66 Irinotecan 66 Navelbine ® 66 Fludara ® 66 Syncria R 66 IMiDs ® compound 66 orally inhaled 66 oxypurinol 66 kidney urologic 66 superficial bladder cancer 66 docetaxel Taxotere R 66 Pivotal Study 66 Enzyme Replacement Therapy 66 Microspheres 66 systemic RNAi therapeutic 66 DURIN TM 66 bevacizumab Avastin R 66 metaglidasen 66 DNA intercalator 66 Granulocyte Colony Stimulating Factor 66 CEQ# 66 Copegus ribavirin 66 TAXOTERE R 66 Monoclonal Antibody 66 Saizen R 66 INTEGRILIN ® 66 Mycophenolate Mofetil 66 Crofelemer budesonide foam 66 corticosteroid dexamethasone 66 Neulasta R 66 CD# CEA 66 Oral Fingolimod 66 irinotecan doxorubicin oxaliplatin paclitaxel 66 PGL# 66 diarrhea predominant irritable 66 Ganciclovir 66 Presents Preclinical 66 GW# [003] 66 Cefazolin 66 sulodexide 66 Vaprisol 66 PKC# 66 Silodosin 66 VNP#M 66 VALSTAR TM 66 investigational humanized monoclonal antibody 66 selective antagonist 66 complement inhibitor eculizumab 66 Anthracycline 66 proteasome inhibitor 66 Onalta TM 66 topical gel formulation 66 Aliskiren 66 Cancidas 66 Maribavir 66 #mg/#mg 66 Dapagliflozin 66 Melphalan 66 macrolide antibiotic 66 Accelerated Partial Breast Irradiation 66 denileukin diftitox 66 CYP#A# CYP#D# 66 adalimumab Humira 66 Receives Orphan Drug 66 imatinib Gleevec ® 66 AEG# 66 Dasatinib 66 Presents Preclinical Data 66 ARRY # 66 Commence Phase 66 ELACYT 66 R roscovitine CDK cyclin 66 Inhalation Aerosol 66 Panzem R 66 highly selective inhibitor 66 familial amyloidotic polyneuropathy FAP 66 PI3K/Akt pathway inhibitor 66 Levoleucovorin 66 polycythemia vera PV 66 Eculizumab 66 Ecallantide 66 Antitumor Activity 66 RELOVAIR ™ 66 oral nucleoside analogue 66 QUADRAMET R 66 R bendamustine hydrochloride 66 Bosutinib 66 brand ciclesonide HFA 66 selective orally bioavailable 66 OvaRex R 66 #I TM# 66 candidate XP# 66 afamelanotide 66 DNA demethylating agent 66 recurrent glioblastoma multiforme 66 Successfully Completes Phase 66 ® bortezomib 66 Voreloxin 66 Mitomycin C 66 prescribed proton pump 66 beta 1a 66 Tumour Vascular Disrupting Agent 66 itraconazole Sporanox 66 Novolimus 66 dihydrochloride Tablets 66 Dacogen decitabine 66 Ribavirin causes 66 plus DOXIL 66 XL# anticancer compounds 66 rasagiline tablets 66 evaluating tivozanib 66 Vandetanib 66 SinuNase ™ 66 evaluating picoplatin 66 BENLYSTA ® 66 Diabetic Macular Edema DME 66 Preclinical studies suggest 66 Clinical Trial Results 66 purpura ITP 66 lymphoid malignancies 66 Efficacy Trial 66 lung pancreatic 66 Onalta ™ 66 modulator SERM 66 mGluR5 NAM 66 p# MAP kinase inhibitor 66 IV Busulfex 66 cetuximab Erbitux ® 66 TELINTRA R 66 Drug Candidate 66 HDAC Inhibitor 66 radiolabeled 66 Kamada AAT 66 thiazolides 66 Letairis ambrisentan 66 Safinamide 66 INVANZ 66 Aplidin 66 Hepatocellular Carcinoma 66 ATPace TM 66 BUPHENYL R 66 synthetic peptide containing 66 Phase IIb clinical trials 66 Cytarabine 66 Phase III Pivotal 66 PEGylated interferon 66 invasive candidiasis 66 Randomized Phase 66 Genasense ® 66 FEMALES SHOULD BE ADVISED 66 anticancer compound 66 depsipeptide 66 FDA APPROVES 66 Tyrima 66 ketolide antibiotic 66 polymerase inhibitor 66 accumulate preferentially 66 taxane resistant 66 Lupus Nephritis 66 Indomethacin 66 sarcoma melanoma 66 Cetuximab Erbitux 66 isoform selective 66 CD3 monoclonal antibody 66 Iluvien ® 66 IgG1 monoclonal antibody 66 hormone agonist 66 herpetic keratitis 66 androgen receptor antagonist 66 relapsing remitting MS RRMS 66 metastatic neuroendocrine tumors 66 Completes Enrollment 66 OMP #R# 66 Initiates Clinical 66 Pralatrexate 66 murine model 66 sodium glucose cotransporter 66 refractory prostate cancer 66 Taxotere chemotherapy 66 oncological indications 65 Lenocta TM 65 alkylating agents 65 ocular formulation 65 Platinol ® cisplatin 65 dexamethasone Decadron 65 Squalamine 65 Myolimus 65 recurrent metastatic ovarian cancer 65 ZEVALIN ® 65 Camptosar ® 65 Sanofi Pasteur Fluzone 65 HER1 65 unresectable tumors 65 gemcitabine cisplatin 65 unresectable HCC 65 Advanced Renal Cell 65 Peginterferon 65 Fondaparinux 65 Pivotal Phase 65 VEGFR2 inhibitor 65 Elotuzumab 65 Neulasta ® 65 Hepatocellular Carcinoma HCC 65 inhibitor RG# 65 Amgen Neulasta R 65 Reports Preclinical Data 65 BCG refractory carcinoma 65 Familial Adenomatous Polyposis FAP 65 CLORETAZINE TM VNP#M 65 Injectable Suspension 65 MTP inhibitor 65 ISTODAX ® 65 MYCAMINE 65 SUPPRELIN R LA 65 albumin bound paclitaxel 65 Glioblastoma Multiforme 65 Opterone R 65 HQK 65 Neupogen ® 65 Factor Receptor 65 Intravitreal injections 65 Haemophilus b Conjugate 65 Xeloda ® 65 dual endothelin receptor antagonist 65 ergot derivatives 65 hA# 65 liposome formulation 65 AVASTIN 65 recurrent NSCLC 65 ibritumomab tiuxetan 65 mGluR5 negative 65 lapatinib Tykerb 65 Angiotensin Converting Enzyme 65 PEG IFN 65 Copegus ® 65 R metformin Concor 65 Squamous 65 R sorafenib tablets 65 Vidofludimus 65 SNT MC# 65 XL# XL# 65 colorectal liver metastases 65 Initiates Phase III 65 Kit CD# positive 65 monoclonal anti 65 microtubule inhibitor 65 Interferon Gamma 65 multi kinase inhibitor 65 haematologic 65 Telik logo TELINTRA 65 galiximab 65 prescription laxative 65 Pegloticase 65 Bendamustine 65 Hodgkin lymphoma HL 65 Vicriviroc 65 Intravesical 65 oral ridaforolimus 65 pediatric pontine glioma 65 Demonstrates Significant 65 Kinoid 65 Platinol ® 65 potassium binder 65 PROCTOCORT R 65 oral rivaroxaban 65 Tigecycline 65 lead molecular radiotherapeutic 65 somatropin Kuvan R 65 AMMONUL R sodium phenylacetate 65 COPEGUS therapy 65 Deforolimus 65 OHR/AVR# 65 opioid induced constipation OIC 65 TRISENOX ® 65 Phase IIb Clinical Trial 65 NAVISTAR R 65 Interferon beta 1a 65 KSP inhibitor 65 octreotide implant 65 Kahalalide F 65 interferon alfa 2b 65 limiting toxicity DLT 65 Sphingosine 1 65 nucleotide analog 65 RNAi Therapeutic 65 rHuPH# recombinant human 65 Mitoxantrone 65 myelofibrosis polycythemia vera 65 Aurora Kinase 65 BEXXAR 65 humanized therapeutic 65 thetreatment 65 Epidermal Growth Factor Receptor 65 BAL# [002] 65 irreversible inhibitor 65 Curaxin CBLC# 65 atypical hemolytic uremic syndrome 65 Allovectin 7 65 radiation sensitizer 65 BUPHENYL R sodium phenylbutyrate 65 albiglutide 65 Pazopanib 65 echinocandin 65 Enzastaurin 65 fumarate 65 indinavir Crixivan 65 Aclidinium 65 uricase 65 alpha 2a 65 CIMZIA R 65 rALLy clinical trial 65 CLL SLL 65 LAB CGRP 65 CINTREDEKIN BESUDOTOX 65 Soft Tissue Sarcoma 65 pathophysiological effects 65 trastuzumab DM1 65 mitoxantrone plus 65 Calcium Acetate 65 TELINTRA 65 oral dual endothelin 65 PRTX 65 selective immunoproteasome inhibitor 65 Zemiva ™ 65 dihydroergotamine 65 fluoroquinolone antibiotic 65 huN# DM1 65 BARACLUDE ® 65 Phase Ib clinical trials 65 proprietary intravenous formulation 65 oral proteasome inhibitor 65 Alferon LDO 65 Exherin TM 65 adult mesenchymal stem 65 FUSILEV ® 65 allosteric modulator NAM 65 receiving prophylactic anticoagulation 65 Inhalation Solution 65 ALVESCO ® 65 Isavuconazole 65 Zavesca R 65 Humanized Anti 65 metal cations 65 Sapacitabine 65 oncolytic virus therapies 65 Bicalutamide 65 administered concomitantly 65 Tyrosine Kinase Inhibitor 65 ZOLINZA 65 lymphomas leukemias 65 Marqibo TM 65 Copegus R 65 Poly ICLC 65 LEP ETU 65 Liposomal 65 imatinib Gleevec 65 Temodar ® 65 nasal calcitonin product 65 induce remission 65 Demonstrates Positive 65 neratinib 65 alkylating 65 Metastatic Colorectal Cancer 65 polycythemia vera essential thrombocythemia 65 tetracycline antibiotic 65 MKC# MKC# PP 65 fluoroquinolone class 65 Calcitonin 65 fluvastatin 65 COLAZAL R 65 Pegylated 65 severe oral mucositis 65 gastrointestinal stromal tumors GIST 65 alfa 2b 65 toenail onychomycosis 65 tubulin inhibitor 65 non porcine pancreatic 65 tazobactam 65 aflibercept VEGF Trap 65 cell carcinoma RCC 65 immunomodulatory properties 65 Adjunctive Therapy 65 Cypher Sirolimus 65 Gleevec Glivec 65 Alocrest 65 Romiplostim 65 zoledronate 65 situ CIS 65 G#DT 65 Investigational Oral 65 Fluorouracil 65 Radiation Therapy SIRT 65 bone marrow reticulin deposition 65 Demonstrates Efficacy 65 ritonavir boosted 65 levocetirizine 65 treat benign prostatic 65 SIR Spheres 65 ORENCIA ® 65 5mg/kg 65 Prodrug 65 hypoxia activated prodrug 65 refractory acute promyelocytic 64 Rituxan rituximab 64 M2 subunit 64 CYP#A# substrate 64 Pivotal Trial 64 temozolomide Temodar 64 Daclizumab 64 etanercept Enbrel 64 apomorphine hydrochloride 64 RNA antagonist 64 TRANSDUR ® 64 oral beclomethasone dipropionate 64 Alinia 64 headache nasopharyngitis 64 quetiapine Seroquel 64 hypervascular tumors 64 MKC# 64 Kuvan R 64 insulin glulisine 64 paclitaxel cisplatin 64 Kepivance 64 plasma kallikrein inhibitor 64 therapeutic monoclonal antibody 64 octreotide acetate 64 assessing T DM1 64 FDA Approvals 64 alvespimycin 64 Pertuzumab 64 Soriatane R 64 Proellex TM 64 Hydrochloride Injection 64 small molecule tyrosine 64 Interferon Beta 64 Dalbavancin 64 1mg 2mg 64 Yondelis ® 64 reduce serum phosphate 64 proprietary polysaccharide 64 LHRH antagonist 64 agonistic human 64 Saquinavir 64 stable nucleic acid 64 ALN TTR 64 novel oral anticoagulant 64 mitogen activated ERK kinase 64 polifeprosan 64 peptidic compound 64 trastuzumab Herceptin R 64 Submits Response 64 inhaled AAT 64 nicardipine 64 Anti Tumor 64 Hycamtin ® 64 pain palliation 64 biliary tract cancer 64 estrogen receptor antagonist 64 Phase 1b clinical trials 64 Homspera TM 64 targeted nucleotide prodrug 64 Dabigatran etexilate 64 receiving highly emetogenic 64 NAGS deficiency 64 KRN# 64 liposomes containing 64 acid phosphatase PAP 64 included exfoliative dermatitis 64 VICTOR E3 64 TPI ASM8 64 Cotara R 64 Doxorubicin 64 YONDELIS R 64 buccal tablets 64 Well Tolerated 64 2 inhibitor CYT# 64 Rigel R# 64 Soriatane 64 MYLOTARG 64 bladder ovarian 64 non resectable metastatic 64 Pruvel TM 64 miconazole Lauriad R 64 AQ4N 64 drug ISA# 64 Advanced Melanoma 64 Cytotoxic 64 docetaxel Taxotere 64 SPL# Gel vaginal microbicide 64 tamoxifen citrate 64 GRASPA ® 64 PHX# 64 Moxifloxacin 64 Study Evaluating 64 TNF alpha selectively neutralizing 64 bortezomib Velcade 64 Leukemias 64 subcutaneous immunoglobulin 64 esophageal candidiasis 64 pharmacokinetic PK study 64 nucleoside analog 64 Muraglitazar 64 reversible inhibitor 64 abacavir Ziagen 64 Improves Outcomes 64 AVONEX ® 64 cetuximab Erbitux 64 platinum chemotherapeutic 64 UPLYSO 64 Etoposide 64 Bayer HealthCare Onyx Pharmaceuticals 64 JAK2 inhibitor 64 phase IIb clinical 64 prucalopride 64 acute HAE attacks 64 Pimavanserin 64 paclitaxel Taxol ® 64 ixabepilone 64 vaccine RiVax TM 64 personalized cellular immunotherapy 64 COLAZAL ® 64 Xelox 64 Cloretazine R 64 lamotrigine Lamictal 64 Brentuximab Vedotin SGN 64 RNAi therapeutic targeting PCSK9 64 TRO# 64 Improves Survival 64 DEFLUX 64 Tyrosine Kinase Inhibitors 64 sodium stibogluconate 64 abacavir sulfate lamivudine 64 Mylan Receives Approval 64 AEGR 64 immunomodulatory therapy 64 lexidronam injection PROSTASCINT 64 TNFerade TM 64 antibiofilm 64 Files Investigational 64 adenosine injection 64 PEGINTRON TM 64 Pegylated interferon 64 Noxafil 64 Soliris eculizumab 64 Solazed 64 Cannabinor 64 anti CD3 monoclonal 64 SCIg 64 selective adenosine 64 Antigen Specific 64 PEG SN# 64 Eluting Stent 64 selective estrogen receptor modulator 64 Oracea TM 64 inhaled iloprost 64 candidate deforolimus 64 PRT# 64 MT# MEDI 64 secondary hyperparathyroidism 64 immunotoxin 64 Phase 2a Clinical Trial 64 Glufosfamide 64 Vivecon 64 ZADAXIN ® 64 Phase 2b Trial 64 Menadione 64 Tanespimycin 64 triggers apoptosis programmed 64 adefovir dipivoxil 64 Pegylated Interferon 64 IAP inhibitor 64 multicenter Phase III 64 selectively inhibited 64 MVA BN 64 triciribine phosphate monohydrate 64 SGPT 64 chronic eosinophilic leukemia 64 Phase IIa Clinical Trial 64 lead Aganocide compound 64 R vitespen 64 Decitabine 64 HCV protease inhibitors 64 Bevacizumab Avastin 64 Tumor Necrosis Factor 64 successfully commercialize Iluvien 64 tiapamil 64 Paraplatin ® carboplatin 64 capsules USP 64 INCB# [003] 64 sodium benzoate prescription 64 benzoic acid hyoscyamine sulfate 64 Transdrug R 64 chemotherapy induced neutropenia 64 Zn DTPA 64 hormone refractory metastatic prostate 64 COPEGUS R 64 basal cell carcinoma BCC 64 EVIZON TM 64 NDA Submission 64 histamine dihydrochloride 64 Relapsed Refractory 64 sulfonylhydrazine class 64 peginterferon alfa 2a Pegasys 64 Campath alemtuzumab 64 RhuDex ® 64 Randomized Double blind 64 sitaxsentan 64 nucleoside reverse transcriptase inhibitor 64 INSPIRE Trial Phase III 64 Parkinson disease levodopa induced 64 hypereosinophilic syndrome 64 tinidazole 64 daily subcutaneous injections 64 BrachySil ™ 64 Vitro Activity 64 Biolimus A9 64 paclitaxel Taxol 64 radezolid 64 Factor VIIa 64 candidemia 64 carcinoma HCC 64 metformin HCl 64 Viread tenofovir disoproxil fumarate 64 Interferon alfa 64 AGGRASTAT R Injection tirofiban 64 topically administered 64 5 HT2A inverse 64 formerly LymphoStat B 64 human C1 inhibitor 64 R bisoprolol Euthyrox 64 Annamycin 64 Epothilone D 64 Denufosol 64 Plus Ribavirin 64 TRAIL R2 64 Topotecan 64 Diabetic Neuropathy 64 metformin hydrochloride 64 KL4 Surfactant 64 taxane chemotherapy 64 Radezolid 64 injected subcutaneously 64 Oral Mucositis 64 Amgen Neulasta ®